Nakijoba, Ritah
Kiguba, Ronald
Dhikusooka, Flavia
Namyenya, Lilliane
Musaazi, Joseph
Atuyambe, Lynn M.
Waitt, Catriona
Article History
Received: 28 April 2025
Accepted: 24 July 2025
First Online: 11 August 2025
Declarations
:
: The study obtained expedited ethical clearance for this study from the institutional review board (IRB) of the Infectious Diseases Institute (SPH-2023-448), Uganda National Council of Science and Technology (HS3166ES).
: Approval was sought from all study participants. The research team provided detailed information about the study objectives, procedures, risks, and benefits both verbally and through written materials. Participants were given time to ask questions and consider their participation. Written informed consent was then obtained from those who voluntarily agreed to participate. Throughout the study, confidentiality was strictly maintained to protect participants’ privacy.
: Not applicable.
: The authors declare no competing interests.